PetIQ Inc (PETQ)
30.98
0.00 (0.00%)
USD |
NASDAQ |
Oct 25, 16:00
PetIQ Debt to Equity Ratio: 1.717 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.717 |
| March 31, 2024 | 1.884 |
| December 31, 2023 | 2.018 |
| September 30, 2023 | 1.886 |
| June 30, 2023 | 1.921 |
| March 31, 2023 | 2.036 |
| December 31, 2022 | 2.153 |
| September 30, 2022 | 2.123 |
| June 30, 2022 | 1.733 |
| March 31, 2022 | 1.859 |
| December 31, 2021 | 1.807 |
| September 30, 2021 | 1.711 |
| June 30, 2021 | 1.744 |
| March 31, 2021 | 1.811 |
| Date | Value |
|---|---|
| December 31, 2020 | 1.866 |
| September 30, 2020 | 1.369 |
| June 30, 2020 | 1.121 |
| March 31, 2020 | 1.123 |
| December 31, 2019 | 0.9014 |
| September 30, 2019 | 0.9021 |
| June 30, 2019 | 0.3619 |
| March 31, 2019 | 0.439 |
| December 31, 2018 | 0.4276 |
| September 30, 2018 | 0.6215 |
| June 30, 2018 | 0.8237 |
| March 31, 2018 | 1.052 |
| December 31, 2017 | 0.2598 |
| September 30, 2017 | 0.2855 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.9014
Minimum
Dec 2019
2.153
Maximum
Dec 2022
1.726
Average
1.811
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| Omeros Corp | -- |
| BioCardia Inc | 0.00 |
| Revance Therapeutics Inc | -3.319 |
| Zevra Therapeutics Inc | 1.796 |
| Alector Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 894.39M |
| Total Liabilities (Quarterly) | 634.08M |
| Shareholders Equity (Quarterly) | 257.97M |
| Current Ratio | 2.579 |
| Net Debt Paydown Yield | 0.23% |